X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - Hier 15:09

Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer

WEDNESDAY, Sept. 18, 2024 -- Neoadjuvant platinum-based chemotherapy improves structure preservation (SP) for patients with T3, T4a, and selected T4b resectable nasal and paranasal sinus squamous cell carcinoma (NPNSCC) requiring orbital or skull...

Articles similaires

Chemotherapy Before Surgery: Improving Organ Preservation in Nose and Sinus Cancer

medindia.net - 16/Sep 11:02

Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with advanced nose and sinus...

Chemotherapy Before Surgery: Improving Organ Preservation in Nose and Sinus Cancer

medindia.net - 16/Sep 11:02

Chemotherapy before surgery improves chances of preserving critical structures like the eye and skull in patients with advanced nose and sinus...

WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only neoadjuvant nivolumab plus chemotherapy for resectable NSCLC

oncologynews.com.au - 13/Sep 02:23

New data from landmark analysis presented today report a decreased risk of disease recurrence or death in patients with resectable NSCLC who received...

Sorry! Image not available at this time

Perioperative Nivolumab Beneficial for Resectable NSCLC

drugs.com - 12/Sep 15:09

THURSDAY, Sept. 12, 2024 -- For patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free...

Chemotherapy Before Surgery: Improving Organ Preservation in Nose and Sinus Cancer

medindia.net - 16/Sep 11:03

Highlights: Chemotherapy before surgery increases organ preservation from 15% to 50% The trial provides a new tr

Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival

medindia.net - 17/Sep 00:35

A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal cancer patients with high...

Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival

medindia.net - 17/Sep 00:35

A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal cancer patients with high...

Sorry! Image not available at this time

Socioeconomic Disparities Impact Immunotherapy Use in Urologic Cancers

drugs.com - 06/Sep 21:37

FRIDAY, Sept. 6, 2024 -- Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with...

Sorry! Image not available at this time

Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer

drugs.com - 12/Sep 21:31

THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...

Sorry! Image not available at this time

Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer

drugs.com - 12/Sep 21:31

THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...